SCHEMBL25918265

SCHEMBL25918265

CC(=O)Nc1cc(CCc2ccc(NC=O)c(F)c2)ccn1

nearest known ligand 0.60

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 14/20 0.60
MAPK13 O15264 3/20 0.53
NR3C2 P08235 6/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23637709 0.81 NR3C2 (0.57) MAPK14MAPK13NR3C2
SCHEMBL29844360 0.77 MAPK14 (0.67) MAPK14MAPK13NR3C2
SCHEMBL23201782 0.77 MAPK14 (0.67) MAPK14MAPK13NR3C2
SCHEMBL25641487 0.76 MAPK14 (0.68) MAPK14MAPK13
SCHEMBL23201670 0.75 MAPK14 (1.00) MAPK14MAPK13
SCHEMBL29844532 0.75 MAPK14 (1.00) MAPK14MAPK13
SCHEMBL23015674 0.75 NR3C2 (0.55) MAPK14NR3C2
SCHEMBL29844362 0.75 MAPK14 (1.00) MAPK14MAPK13
SCHEMBL29844394 0.75 MAPK14 (1.00) MAPK14MAPK13
SCHEMBL23201717 0.75 MAPK14 (1.00) MAPK14MAPK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219489-A2 MITOGEN-ACTIVATED PROTEIN KINASE INHIBITORS, METHODS OF MAKING, AND METHODS OF USE THEREOF Washington University (US) 2023-08-02 EP disclosed